deListed Australia
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


ASX Announcements (courtesy of ASX)


ASX, Legal & CGT Status


(updated at weekends)
2017 2018 2020   ALL
Former (or subsequent) names
Shareholder links


Computershare Adelaide
Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail

Company details
ISIN: AU000000MHD7
Address: Suite 145, Regis Tower, 416-418 Pitt Street, Sydney, NSW, AUSTRALIA, 2000
Tel:  (02) 92124881 Fax: (02) 83246353

Date first listed: 20/03/2009

Sector: Consumer Durables & Apparel
Industry Group: XDJ
Activities: Supply and marketing of high-end fabrics, home textiles and luxury fashion decor globally

company deregistered today


Sule Arnautovic and John Vouris of Hall Chadwick appointed liquidators


delisted from the commencement of trading on Friday, 14 August 2020, pursuant to Listing rule 17.12.


we understand this company failed and ASX removed the company from listing because its securities have been suspended from trading for a period of two years


The company has withdrawn the offer under the replacement prospectus for its proposed acquisition of Advent Health. ASX has advised to revoke the extension of removal date provided on 23 July 2020 given MHD is no longer in the final stage of implementing a transaction that will lead to the resumption of trading in its securities. ASX will remove MHD from the official list of ASX from the open of trading on 14 August 2020.


The company has withdrawn the offer under the replacement prospectus dated 18 May 2020. While there has been considerable interest in Advent Health during the offer period from private and institutional investors, Advent Health will be considering alternative capital raising strategies including from private equity firms.


The company lodges an Appendix 4C - quarterly.


The company sought an extension of its removal date from ASX to allow the company further time to complete its proposed acquisition, capital raising and recompliance with Chapter 1 and 2 of the Listing Rules. ASX has granted an extension to MHD's removal date from 13 August 2020 to 13 November 2020. ASX has further advised that this is a one-off extension and no further extension will be provided beyond 13 November 2020. MHD must demonstrate compliance with Chapter 1 and 2 of the Listing Rules by that date, in the event that MHD has not satisfied the readmission criteria by 13 November 2020, it will be removed from the Official List on 14 November 2020.


The Board has resolved to extend the closing date of the public offer. The offer will now close on 31 July 2020 at 5pm, subject to the right of the company to close the public offer early or further extend the closing date.


The company has lodged a replacement prospectus with Australian Securities and Investments Commission on 18 May 2020. This is in response to the interim stop order issued by ASIC on the prospectus dated 13 March 2020 which has now been removed by ASIC. Forecasts for FY20 and FY21 have been removed at the request of ASIC as they could be subject to such a broad range of potential outcomes, making them confusing and potentially misleading. An analysis of trends since the start of the lockdowns give the Directors reason to be cautiously optimistic that historic profitability levels of the group overall will be restored in the coming months. An analysis of the weekly revenue figures for the group from the middle of March to the first week in May show the weekly aggregated revenues declined up to a peak of approximately 30% in midApril (or 20% if seasonally adjusted for Easter) and are now running at an approximately 10 to 15% below trend but on an upward trajectory. The majority of practice groups anticipate returning to pre-COVID-19 revenues or single digit revenue reductions in the next four to six weeks.


The company lodges its Appendix 4C - quarterly.


The company releases a disclosure document. Allied health services remain an "essential" service and are therefore continuing. Allied health services promote health and consequently patients require less visits to the General Practitioner and other emergency in-demand services. The Advent Health group is well positioned to respond to the current COVID-19 conditions. The Directors believe it is prudent to assess the impact of the COVID-19 pandemic on the group businesses including the FY21 forecast in the prospectus. Due to the level of uncertainty resulting from the COVID-19 pandemic, on 2 April 2020, ASIC issued an interim stop order in relation to the Prospectus. No offers, issues, sales or transfers of shares can be made under the Prospectus while the interim stop order is in force. The Company expects to lodge a Replacement Prospectus addressing the concerns raised by ASIC.


The company releases the typeset version of the prospectus to replace the word version lodged on 13 Marhc 2020. The typeset version of the prospectus corrected a number of graphic tables which were not properly shown. It includes images and illustrations, and the contents has no material changes.


The Company issues a prospectus for the offer of 21,000,000 fully paid ordinary shares to the public at an Offer Price of $1.00 per share to raise up to $21,000,000. The Company has entered into an agreement for the acquisition of 100% of the issued capital of Advent Health. AHPL has in turn entered into agreements to acquire a number of multi-disciplinary allied health practices. The Acquisitions will involve a significant change in the nature and scale of the Company's activities, which requires the approval of Shareholders under Chapter 11 of the ASX Listing Rules.


The company lodges its Half Yearly Report and Accounts.


The company lodges its Appendix 4C - quarterly.


The company releases the results of its meeting.


The company releases the Chairman's Address to Shareholders.


The company's AGM will be held at 9U, 175 Lower Gibbes Street, Chatswood NSW 2067 at 11:00 am Sydney time on Friday 29 November 2019.


The company lodges its Appendix 4C - quarterly.


The company releases its Appendix 4G Corporate Governance Disclosure.


The company lodges its Annual Report to shareholders.


The company lodges an Appendix 4C - quarterly.


The company lodges an Appendix 4C - quarterly.


The company lodges its Half Yearly Report and Accounts.


The company lodges an Appendix 4D.


The company issues a response to ASX Query regarding its Appendix 4C.


The company will repay the A$1.5 million of Convertible Notes currently on issue. An agreement between the Company and the Notes Holder has been signed for MHD to redeem all Notes that are outstanding on 12 February 2019. MHD will now redeem all Convertible Notes at the price of A$1.00 per Note (total A$1,500,000) and any interest accrued up to the Early Redemption Date (total A$193,438) as per the terms of the Convertible Notes Deed. The Early Redemption will save the Company approximately $186,000 in future interest payments.


Settlement of 47 Brookes Street Bowen Hills Property occurred on 31 January 2019.


The company lodges its Appendix 4C - quarterly.


The company releases the Results of Meeting.


The company releases the Chairman's Address to Shareholders.


The company lodges its Appendix 4C - quarterly.


The company releases a notice of AGM and proxy form. The Annual General Meeting of the Shareholders of Millennium Limited will be held at Unit 9U, 175 Lower Gibbes Street, Chatswood, NSW 2067, Australia, on Thursday, 8 November 2018 at 11:00 am.


The company releases its Appendix 4G Corporate Governance Disclosure.


The company lodges its Annual Report to shareholders.


The securities of Millennium Limited will be suspended from quotation immediately in accordance with Listing Rule 17.3, as ASX has determined that the Company's operations are not adequate to warrant the continued quotation of its securities and therefore it is in breach of Listing Rule 12.1. The suspension will continue until the Company is able to demonstrate compliance with Listing Rule 12.1 of the Listing Rules.


name changed from Yanghao International Limited

View ASX Announcements (courtesy of ASX)


Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

can you cristilize my losses in millenium 440000 shares

21/09/2020 14:40:08
Company Updates
Post your comments here
Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)


    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    Wei HuangNon Exec Director28/11/2008
    Bryce WedemeyerNon Exec Director13/03/2020
    Cris MassisExecutive Director13/03/2020

    Date of first appointment, title may have changed.

    Directors & Executives (former)
    Yan YangExecutive Chairman21/05/201413/03/2020
    Ying HuangNon Exec Director, Company Secretary26/11/201513/03/2020
    Jiang SongExecutive Director07/09/201513/03/2020
    Cathy GuoIndependent Director19/04/201126/11/2015
    Jie YangAlternate Director27/08/201007/09/2015
    Xuefu YangExecutive Director05/05/201021/04/2014
    Jack HuangNon Exec Director13/10/200805/07/2011

    Date of first appointment, title may have changed.